Cellular responses to a prolonged delay in mitosis are determined by a DNA damage response controlled by Bcl-2 family proteins

Open Biology

Volumn 5, Issue 3, 2015, Pages

  Colin, Didier J ^a   Hain, Karolina O ^a   Allan, Lindsey A ^a   Clarke, Paul R ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Apoptosis; Caspase; DNA damage response; Mitosis; Paclitaxel

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; HISTONE; NOCODAZOLE; PROTEIN BCL 2; PROTEIN KINASE INHIBITOR; PROTEIN MCL 1; PROTEIN P53; TUBULIN MODULATOR;

APOPTOSIS; BIOLOGICAL MODEL; CELL CYCLE CHECKPOINT; DNA DAMAGE; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; MICROTUBULE; MITOSIS; PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; DNA DAMAGE; HISTONES; HUMANS; MICROTUBULES; MITOSIS; MODELS, BIOLOGICAL; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; NOCODAZOLE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUBULIN MODULATORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84925763790     PISSN: None     EISSN: 20462441     Source Type: Journal    
DOI: 10.1098/rsob.140156     Document Type: Article

References (42)

1. Foley EA, Kapoor TM. 2013 Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore. Nat. Rev. Mol. Cell Biol. 14, 25-37. (doi:10.1038/nrm3494)
2. Allan LA, Clarke PR. 2007 Phosphorylation of caspase-9 by CDK1/cyclin B1 protects mitotic cells against apoptosis. Mol. Cell 26, 301-310. (doi:10.1016/j.molcel. 2007.03.019)
3. Bekier ME, Fischbach R, Lee J, Taylor WR. 2009 Length of mitotic arrest induced by microtubulestabilizing drugs determines cell death after mitotic exit. Mol. Cancer Ther. 8, 1646-1654. (doi:10.1158/1535-7163. MCT-08-1084)
4. Huang HC, Shi J, Orth JD, Mitchison TJ. 2009 Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly. Cancer Cell 16, 347-358. (doi:10.1016/j.ccr.2009.08.020)
5. Brito DA, Rieder CL. 2006 Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr. Biol. 16, 1194-1200. (doi:10.1016/j.cub.2006.04.043)
6. Gascoigne KE, Taylor SS. 2008 Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 14, 111-122. (doi:10.1016/j.ccr.2008.07.002)
7. Rieder CL, Maiato H. 2004 Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev. Cell 7, 637-651. (doi:10.1016/j.devcel.2004.09.002)
8. Shi J, Orth JD, Mitchison T. 2008 Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5. Cancer Res. 68, 3269-3276. (doi:10.1158/0008-5472. CAN-07-6699)
9. Manchado E et al. 2010 Targeting mitotic exit leads to tumor regression in vivo: modulation by Cdk1, Mastl, and the PP2A/B55α, δ phosphatase. Cancer Cell 18, 641-654. (doi:10.1016/j.ccr.2010.10.028)
10. Clarke PR, Allan LA. 2009 Cell-cycle control in the face of damage: a matter of life or death. Trends Cell Biol. 19, 89-98. (doi:10.1016/j.tcb.2008. 12.003)
11. Harley ME, Allan LA, Sanderson HS, Clarke PR. 2010 Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest. EMBO J. 29, 2407-2420. (doi:10. 1038/emboj.2010.112)
12. Wertz IE et al. 2011 Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 471, 110-114. (doi:10.1038/nature09779)
13. Terrano DT, Upreti M, Chambers TC. 2010 Cyclindependent kinase 1-mediated Bcl-xL/Bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis. Mol. Cell. Biol. 30, 640-656. (doi:10.1128/MCB.00882-09)
14. Uetake Y, Sluder G. 2010 Prolonged prometaphase blocks daughter cell proliferation despite normal completion of mitosis. Curr. Biol. 20, 1666-1671. (doi:10.1016/j.cub.2010.08.018)
15. Hayashi MT, Cesare AJ, Fitzpatrick JA, Lazzerini-Denchi E, Karlseder J. 2012 A telomere-dependent DNA damage checkpoint induced by prolonged mitotic arrest. Nat. Struct. Mol. Biol. 19, 387-394. (doi:10.1038/nsmb.2245)
16. Imreh G, Norberg HV, Imreh S, Zhivotovsky B. 2011 Chromosomal breaks during mitotic catastrophe trigger γH2AX-ATM-p53-mediated apoptosis. J. Cell Sci. 124, 2951-2963. (doi:10.1242/jcs.081612)
17. Orth JD, Loewer A, Lahav G, Mitchison TJ. 2012 Prolonged mitotic arrest triggers partial activation of apoptosis, resulting in DNA damage and p53 induction. Mol. Biol. Cell 23, 567-576. (doi:10. 1091/mbc. E11-09-0781)
18. Crighton D, O'Prey J, Bell HS, Ryan KM. 2007 p73 regulates DRAM-independent autophagy that does not contribute to programmed cell death. Cell Death Differ. 14, 1071-1079. (doi:10.1038/sj.cdd. 4402108)
19. Aylon Y, Michael D, Shmueli A, Yabuta N, Nojima H, Oren M. 2006 A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev. 20, 2687-2700. (doi:10.1101/gad.1447006)
20. Chou TC. 2010 Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 70, 440-446. (doi:10.1158/0008-5472. CAN-09-1947)
21. Jackson SP, Bartek J. 2009 The DNA-damage response in human biology and disease. Nature 461, 1071-1078. (doi:10.1038/nature08467)
22. So S, Davis AJ, Chen DJ. 2009 Autophosphorylation at serine 1981 stabilizes ATM at DNA damage sites. J. Cell Biol. 187, 977-990. (doi:10.1083/jcb. 200906064)
23. Nguyen M et al. 2007 Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis. Proc. Natl Acad. Sci. USA 104, 19 512-19 517. (doi:10.1073/pnas. 0709443104)
24. Hickson I et al. 2004 Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 64, 9152-9159. (doi:10.1158/0008-5472. CAN-04-2727)
25. Peasland A et al. 2011 Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines. Br. J. Cancer 105, 372-381. (doi:10.1038/bjc.2011.243)
26. Leahy JJ, Golding BT, Griffin RJ, Hardcastle IR, Richardson C, Rigoreau L, Smith GC. 2004 Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries. Bioorg. Med. Chem. Lett. 14, 6083-6087. (doi:10. 1016/j.bmcl.2004.09.060)
27. Zhao Y et al. 2006 Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441. Cancer Res. 66, 5354-5362. (doi:10.1158/0008-5472. CAN-05-4275)
28. Toledo LI et al. 2011 A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations. Nat. Struct. Mol. Biol. 18, 721-727. (doi:10.1038/nsmb.2076)
29. Jackson JR, Gilmartin A, Imburgia C, Winkler JD, Marshall LA, Roshak A. 2000 An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage. Cancer Res. 60, 566-572.
30. Tse C et al. 2008 ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res. 68, 3421-3428. (doi:10.1158/0008-5472. CAN-07-5836)
31. Shi J, Zhou Y, Huang HC, Mitchison TJ. 2011 Navitoclax (ABT-263) accelerates apoptosis during drug-induced mitotic arrest by antagonizing Bcl-xL. Cancer Res. 71, 4518-4526. (doi:10.1158/0008-5472. CAN-10-4336)
32. Andersen JL et al. 2009 Restraint of apoptosis during mitosis through interdomain phosphorylation of caspase-2. EMBO J. 28, 3216-3227. (doi:10.1038/emboj.2009.253)
33. Tait SW, Parsons MJ, Llambi F, Bouchier-Hayes L, Connell S, Munoz-Pinedo C, Green DR. 2010 Resistance to caspase-independent cell death requires persistence of intact mitochondria. Dev. Cell 18, 802-813. (doi:10.1016/j.devcel.2010.03.014)
34. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. 1998 A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391, 43-50. (doi:10.1038/34112)
35. Orthwein A, Fradet-Turcotte A, Noordermeer SM, Canny MD, Brun CM, Strecker J, Escribano-Diaz C, Durocher D. 2014 Mitosis inhibits DNA doublestrand break repair to guard against telomere fusions. Science 344, 189-193. (doi:10.1126/science.1248024)
36. Giunta S, Belotserkovskaya R, Jackson SP. 2010 DNA damage signaling in response to double-strand breaks during mitosis. J. Cell Biol. 190, 197-207. (doi:10.1083/jcb.200911156)
37. Janssen A, Van Der Burg M, Szuhai K, Kops GJ, Medema RH. 2011 Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science 333, 1895-1898. (doi:10.1126/science.1210214)
38. Crasta K et al. 2012 DNA breaks and chromosome pulverization from errors in mitosis. Nature 482, 53-58. (doi:10.1038/nature10802)
39. Hatch EM, Fischer AH, Deerinck TJ, Hetzer MW. 2013 Catastrophic nuclear envelope collapse in cancer cell micronuclei. Cell 154, 47-60. (doi:10.1016/j.cell. 2013.06.007)
40. Loughery J, Cox M, Smith LM, Meek DW. 2014 Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters. Nucleic Acid Res. 42, 7666-7680. (doi:10.1093/nar/gku501)
41. Yang Z, Loncarek J, Khodjakov A, Rieder CL. 2008 Extra centrosomes and/or chromosomes prolong mitosis in human cells. Nat. Cell Biol. 10, 748-751. (doi:10.1038/ncb1738)
42. Park YB, Park MJ, Kimura K, Shimizu K, Lee SH, Yokota J. 2002 Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines. Cancer Genet. Cytogenet. 133, 105-111. (doi:10.1016/S0165-4608 (01) 00575-1)